There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...

There has been a lasting and disproportionate impact of the COVID-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis.

Select your location to view local American Lung Association events and news near you.

Improved insurance coverage and increasing healthcare expenditure have expanded access to therapies and propelled affordability, thus driving growth of the asthma and COPD drugs market. Growing ...

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need for early intervention is important.

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won European regulatory approval for two inflammatory disease indications. The European Medicines Agency's ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...